Hypertension

Comprehensive Medicinal Chemistry II

Volumn 6, Issue , 2006, Pages 705-728

  Scriabine, A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35148817696     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (52)

1. Chobanian, A. V; Bakris, G. L.; Black, H. R.; Cushman, W C.; Green, L. A.; Izzo, J. L., Jr.; Jones, D. W; Materson, B. J.; Oparil, S.; Wright, J. T, Jr. et al. J. Hypertens. 2003, 42, 1206-1252.
2. Lloyd-Jones, D. M.; Evans, J. C.; Larson, M. G.; Levy, D. Hypertension 2002, 40, 640-646.
3. Lloyd-Jones, D. M.; Evans, J. C.; Levy, D. JAMA 2005, 294, 466-472.
4. Valderrabano, F; Gomez-Campdera, F; Jones, E. H. Kidney Int. 1998, 68, S60-S66.
5. Lloyd, A.; Schmieder, C.; Marchant, N. Pharmacoeconomics 2003, 21, 33-41.
6. Banegas Banegas, J. R. An. Real Acad. Nac. Med. 2002, 119, 143-152.
7. Takahashi, N.; Smithies, O. Trends Genet. 2004, 20, 136-145.
8. Timberlake, D. S.; O'Connor, D. T; Parmer, R. Curr. Opin. Nephrol. Hypertens. 2001, 10, 71-79.
9. Saeed, M. M.; Saboohi, K.; Osman, A. S.; Bokhari, A. M.; Frossard, P. M. J. Hum. Hypertens. 2003, 17, 719-723.
10. Baudin, B. Pharmacogenomics 2002, 3, 65-73.
11. Hannila-Handelberg, T; Kontula, K.; Tikkanen, I.; Tikkanen, T; Fyhrquist, F; Helin, K.; Fodstad, H.; Piippo, K.; Miettinen, H. E.; Virtamo, J. et al. BMC Med. Genet. 2005, 6, 4.
12. Ruppert, V; Maisch, B. Herz 2003, 28, 655-662.
13. Nesbitt, S. D. Curr. Cardiol. Rep. 2004, 6, 416-420.
14. Wiesel, P; Mazzolai, L.; Nussberger, J.; Pedrazzini, T Hypertension 1997, 29, 1025-1030.
15. Cervenka, L.; Horácek, V; Vaneckova, I.; Hubacek, J. A.; Oliverio, M. I.; Coffman, T M.; Navar, L. G. Hypertension 2002, 40, 735-741.
16. van den Meiracker, A. H. J. Hypertens. 2002, 20, 587-589.
17. Iglarz, M.; Touyz, R. M.; Viel, E. C.; Paradis, P; Amiri, F; Diep, Q. N.; Schiffrin, E. L. Hypertension 2003, 42, 737-743.
18. Rossi, G. P; Colonna, S.; Belloni, A. S.; Savoia, C.; Albertin, G.; Nussdorfer, G. G.; Hagiwara, H.; Rubattu, S.; Volpe, M. J. Hypertens. 2003, 21, 105-113.
19. Manger, W M.; Simchon, S.; Stier, C. T, Jr.; Loscalzo, J.; Jan, K. M.; Jan, R.; Haddy, F J. Hypertension 2003, 21, 2305-2313.
20. Lighthall, G. K.; Hamilton, B. P; Hamlyn, J. M. J. Hypertens. 2004, 22, 1487-1494.
21. Ferrari, P; Torielli, L.; Ferrandi, M.; Padoani, G.; Duzzi, L.; Florio, M.; Conti, F; Melloni, P; Vesci, L.; Corsico, N. et al. J. Pharmacol. Exp. Ther. 1998, 285, 83-94.
22. Dominiczak, A. F; Negrin, D. C.; Clark, J. S.; Brosnan, M. J.; McBride, M. W; Alexander, M. Y Hypertension 2000, 35, 164.
23. Stier, C. T, Jr. Cardiovasc. Drug Rev. 2003, 21, 169-184.
24. Croom, K. F; Perry, C. M. Am. J. Cardiovasc. Drugs 2005, 5, 51-69.
25. Paget, C. F Br. Med. J. 1963, 2, 1266-1271.
26. Cheng, J.; Kamiya, K.; Kodama, I. Cardiovasc. Drug Rev. 2001, 19, 152-171.
27. Kuroedov, A.; Cosentino, F; Lüscher, T F Cardiovasc. Drug Rev. 2004, 22, 155-168.
28. Hernandez Hernandez, R.; Angeli-Greaves, M.; Carvajal, A. R.; Guerrero Pajuelo, J.; Armas Padilla, M. C.; Armas-Hernandez, M. J. Am. J. Hypertens. 1996, 9, 437-444.
29. Meredith, P. A. Cardiology 2001, 96, 1-19.
30. Barzilay, J. I.; Davis, B. R.; Bettencourt, J.; Margolis, K. L.; Goff, D. C., Jr.; Black, H.; Habib, G.; Ellsworth, A.; Force, R. W; Wiegmann, T et al. J. Clin. Hypertens. 2004, 6, 116-125.
31. Dutkiewicz, S. Int. Urol. Nephrol. 2004, 36, 169-173.
32. Xu, K.; Wang, X.; Ling, P M.; Tsao, S. W; Wong, Y C. Oncol Rep. 2003, 10, 1555-1560.
33. Vater, W; Kroneberg, G.; Hoffmeister, F; Kaller, H.; Meng, K.; Oberdorf, A.; Puls, W; Schloßmann, K.; Stolpel, K. Arzneimittelforschung 1972, 22, 1-14.
34. Furberg, C. D.; Psaty, B. M.; Meyer, J. V Circulation 1995, 92, 1326-1331.
35. Epstein, M. Safety of Calcium Antagonists as Antihypertensive Agents: An Update. In Calcium Antagonists in Clinical Medicine, 3rd ed; Epstein, M., Ed.; Hanley & Belfus: Philadelphia, PA, 2002, pp 807-832.
36. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension. J. Hypertens. 1997, 15, 105-115.
37. Meredith, P A.; Elliott, H. L. J. Hypertens. 2004, 22, 1641-1648.
38. Piepho, R. W. Am. J. Health-System Pharmacy 2000, 57, S3-S7.
39. Powell, J. R.; Reeves, R. A.; Marino, M. R.; Cazaubon, C.; Nusato, D. Cardiovasc. Drug Rev. 1998, 16, 169-194.
40. Wienen, W; Entzeroth, M.; van Meel, J. C. A.; Stangier, J.; Busch, U.; Schmid, J.; Lehmann, H.; Matzek, K.; Kempthorne-Rawson, G. V; Hauel, N. H. Cardiovasc. Drug Rev. 2000, 18, 127-156.
41. Gleiter, C. H.; Jagle, C.; Gresser, U.; Mörike, K. Cardiovasc. Drug Rev. 2004, 22, 263-284.
42. Stanton, A.; Jensen, C.; Nussberger, J.; O'Brien, E. Hypertension 2003, 42, 1137-1143.
43. Trippodo, N. C.; Robl, J. A.; Asaad, M. M.; Fox, M.; Panchal, B. C.; Schaeffer, T R. Am. J. Hypertens. 1998, 11, 363-372.
44. Zanchi, A.; Maillard, M.; Burnier, M. Curr. Hypertens. Rep. 2003, 5, 346-352.
45. Lilienfeld, D. E.; Rubin, L. J. Chest 2000, 117, 796-800.
46. Rashid, A.; Lahrman, S.; Romano, P; Frishman, W; Dobkin, J.; Reichel, J. Heart Dis. 2000, 2, 422-30.
47. Cohen, H.; Chahine, C.; Hui, A.; Mukherji, R. Am. J. Health-System Pharmacy 2004, 61, 1107-1119.
48. Lin, H. C.; Yang, Y Y; Hou, M. C.; Huang, Y T; Lee, F Y; Lee, S. D. Am. J. Gastroenterol. 2004, 99, 1953-1958.
49. Jamerson, K. A.; Bakris, G. L.; Wun, C. C.; Dahlof, B.; Lefkowitz, M.; Manfreda, S.; Pitt, B.; Velazquez, E. J.; Weber, M. A. Am. J. Hypertens. 2004, 17, 793-801.
50. McKay, M. J.; Gaballa, M. A. Cardiovasc. Drug Rev. 2001, 19, 245-262.
51. Pachori, A. S.; Huentelman, M. J.; Francis, S. C.; Gelband, C. H.; Katovich, M. J.; Raizada, M. K. Hypertension 2001, 37, 357-364.
52. Tomita, N.; Morishita, R. Curr. Pharm. Design 2004, 10, 797-803.